ASCO 2020：11项近现代研究入选口头报告，17项Poster报告

受亚洲地区取而代之冠鼠疫影响，原定于5月29日~6月2日在波士顿举行的美国政府临床学会（ASCO）年会来年将首次以站起站上形式筹办，这是目前最大规模的站起站上盛宴。直到现在，开会的概述出题公布，共103个sessions，之前国仅有11项科学研究跻身口头报告，17项跻身Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

吡咯替尼或拉帕替尼加卡培他埠头用以HER2+乳腺癌乳腺恶连续性肿瘤（PHOEBE）：一项III期随机飞行测试。

艺术节：乳腺癌乳腺恶连续性肿瘤

创作者：医科的医院徐兵河系主任、马飞系主任，复旦大学医科胡夕春系主任等

概述号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可手术三相似连续性连续性乳腺恶连续性肿瘤标准病患后卡培他埠头维持节拍肌肉注射的III期飞行测试（SYSUCC-001）。

艺术节：乳腺恶连续性肿瘤—大面积/范围内/特别设计病患

创作者：之前山大学传染病该之前心王于树森系主任等

概述号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

利用乳腺癌脑的表型相似连续性来假设十二指肠之前循环DNA检测的概率: 取而代之物件抗衡杨家对手

艺术节：取而代之物件解决杨家弱点

创作者：郭美芹 郭德兰等

概述号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

了了非尼对布基纳法索拉非尼作为早期肾细胞内恶连续性肿瘤的一站起站病患：一项解禁标记、随机、多该之前心II/III期飞行测试。

艺术节：食道肠道恶连续性肿瘤—食道十二指肠、肾上腺和肾胆

创作者：四川大学毛脉的医院毕锋系主任、之前国老百姓解放军八一的医院秦叔逵系主任等

概述号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

之前国早期肾恶连续性肿瘤病变阿帕替尼中卫病患：一项随机、安慰剂解读、临床III期科学研究

艺术节：食道肠道恶连续性肿瘤—食道十二指肠、肾上腺和肾胆

创作者：之前国老百姓解放军八一的医院秦叔逵系主任、四川大学毛脉的医院郭秋系主任等

概述号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

早期入院连续性卵巢恶连续性肿瘤二次细胞内减灭术的一项随机III期飞行测试：SOC1 / SGOG-OV2。

讲座：诊疗恶连续性肿瘤症

创作者：复旦大学附属之前山的医院臧荣余系主任等

概述：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈恶连续性肿瘤根治连续性子宫切除术后特别设计病患之前的序贯放肌肉注射对比基本上放疗或同步放肌肉注射（STARS科学研究）：一项随机、解读、解禁标记的III期飞行测试。

开会：诊疗恶连续性肿瘤症

创作者：之前山大学传染病该之前心黄鹤系主任、刘继红系主任等

概述号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：特别设计吉非替尼对比肌肉注射用以可切除的EGFR等位基因的N1-N2期NSCLC-随机III期临床飞行测试的最终总体求生归纳。

讲座：肺恶连续性肿瘤—非小细胞内大面积-范围内/小细胞内/其他胸部

创作者：东莞市老百姓的医院吴一龙系主任等

概述号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR等位基因寡转移非小细胞内肺恶连续性肿瘤病变一站起站色氨酸激酶类固醇倡议或不倡议积极前站起站大面积放疗：III期解禁标记临床随机飞行测试（SINDAS）的之前期结果（NCT02893332）。

讲座：肺恶连续性肿瘤-非小细胞内转移

创作者：乐山市老百姓的医院曾铭系主任等

概述：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对程序连续性死亡-1（PD-1）的人源化IgG4单克隆抗体倡议阿昔替尼用以乳腺癌黏膜前列腺癌病变的Ib期科学研究的总求生期和生物标志物归纳。

讲座：前列腺癌/皮肤恶连续性肿瘤

创作者：北京大学的医院郭军、盛锡楠系主任等

概述：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的可靠连续性和结果：通用CAR-T细胞内首次人体飞行测试病患入院/难治连续性T细胞内急连续性淋巴细胞内白血病（r/r T-ALL）的可靠连续性和。开会：开发设计之前的病患高效率-免疫病患。创作者：王于欣欣等概述：3013的广告：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利类药物在早期十二指肠突起细胞内恶连续性肿瘤病变之前的运用以：一项随机的解禁标记II期飞行测试（ORIENT-2）。开会：食道肠道恶连续性肿瘤-食道十二指肠恶连续性肿瘤、肾上腺恶连续性肿瘤和肾胆道恶连续性肿瘤创作者：徐建明系主任等概述：4511的广告：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D特异连续性CAR-T细胞内对脾脑瘤的根除连续性病患开会：之前枢神经系统创作者：代红久、孙斌、杨东、徐晖、朱晶晶、魏佳、杨旭东概述：2522的广告。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在早期错配修复弱点病变之前的运用以开会：开发设计之前的病患学-免疫病患创作者：沈琳系主任等概述：3021的广告。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 自体CD7-CART病患入院/难治连续性ACUTE淋巴细胞内白血病/帕金森氏症的月所人体临床飞行测试开会: 开发设计连续性病患学-免疫病患创作者简介：张明志，白水等概述：3026的广告: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 西米替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度咪唑（T）倡议引入早期实体瘤病变的Ib期科学研究开会：发展连续性病患学便是分子靶向药物和生物学创作者：龚继芳，沈琳系主任等概述：3523的广告：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin倡议紫杉醇和nedaplatin病患入院连续性或乳腺癌十二指肠突起细胞内恶连续性肿瘤（ESCC）病变的II期科学研究。开会：食道肠道恶连续性肿瘤-食道十二指肠、肾上腺和肾胆道恶连续性肿瘤的科学研究创作者：王于志弱，郭玉红，王于德申，王于凤华，任超，谭琼 王于志弱、郭玉红、王于德深、王于凤华、任超、谭琼概述：4522的广告：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.开会：食道肠道恶连续性肿瘤-食道十二指肠恶连续性肿瘤、肾上腺恶连续性肿瘤和肾胆管恶连续性肿瘤的中卫病患创作者：宋艳等概述：4524的广告：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种尿液外体外侧RNA分类器用以初始活检时检测高等级恶连续性肿瘤的尿液外体外侧RNA分类器：一项多该之前心的回顾连续性科学研究开会：消化系统生殖系统恶连续性肿瘤症便是-恶连续性肿瘤、睾丸恶连续性肿瘤和恶连续性肿瘤创作者简介：Liaoyuan Li等概述：5522的广告。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 大面积早期宫颈恶连续性肿瘤并作肌肉注射后的特别设计肌肉注射开会: 诊疗恶连续性肿瘤症创作者简介： 郭珉珉等概述：6031的广告：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼病患甲状腺脾连续性恶连续性肿瘤的连续连续性：基于ALTER01031飞行测试的归纳。会话：外周创作者：上海市的医院正派系主任概述：6526的广告。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、大小和比率对安洛替尼病患后病变结局的影响: ALTER01031的亚组归纳开会：外周创作者：上海市的医院正派系主任概述：6527的广告。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA归纳假设I-IIIA期非小细胞内肺恶连续性肿瘤（NSCLC）病变术后入院: GASTO1035和GASTO1018的结果开会：肺恶连续性肿瘤-非小细胞内大面积-邻近地区/小细胞内/小细胞内/其他胸科恶连续性肿瘤症创作者：Si-Yu Wang等概述：9023的广告：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小细胞内肺恶连续性肿瘤（NSCLC）之前EGFR色氨酸激酶类固醇的取而代之型耐药机制开会:肺恶连续性肿瘤-非小细胞内乳腺癌肺恶连续性肿瘤创作者简介：杨昕，金MLT-，满宇，欧元人，华宝，薛武，杨少，范敏 杨昕、金MLT-、满宇、欧元人、华宝、薛武、杨绍、范敏概述：9528的广告：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1飞行测试之前早期前列腺癌总求生的替代站起开会：前列腺癌/皮肤恶连续性肿瘤创作者：聂润聪，袁书弱，郭元芳，陈英波，周志伟 聂润聪、袁书弱、郭元芳、陈英波、周志伟概述：10030的广告：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼病患入院或乳腺癌原发连续性恶连续性骨头病变的II期科学研究开会： 肉瘤创作者：唐丽娜，牛晓辉，王于震，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、王于振、蔡启庆、涂崇奇、范正福、杨瑶概述：11525的广告。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 近期评价安罗替尼在早期肉瘤病变多站起站病患之前的可靠连续性和。开会：肉瘤创作者：姚伟涛，王于家弱，王永，王于欣，杜取而代之辉，田志浩，牛晓颖 姚伟涛、王于家弱、王永、王于鑫、杜鑫辉、田志超、牛晓英概述：11526的广告：414